ICM
LJPC

ISZO Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

ISZO Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$924K Buy
+30,967
New +$791K 1.61% 14

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

ISZO Capital Management's LJPC Position: Q1 2017 in Review

ISZO Capital Management opened a new position in La Jolla Pharmaceutical Company (LJPC) in Q1 2017: 30,967 shares worth $924K. The stake represents 1.61% of the portfolio and ranks #14 among its holdings.

96 funds tracked by Wall St. Rank hold LJPC as of Q1 2017.

  • ISZO Capital Management held 30,967 shares of La Jolla Pharmaceutical Company worth $924K as of Q1 2017.
  • La Jolla Pharmaceutical Company was a new ISZO Capital Management position in Q1 2017.
  • La Jolla Pharmaceutical Company made up 1.61% of ISZO Capital Management's portfolio in Q1 2017, its #14 holding.
  • 96 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2017.

Based on ISZO Capital Management's 13F filing for Q1 2017, filed 15 May 2017.